Investments
Epizyme, Inc.
Biopharmaceutical company that is creating innovative drugs for major diseases based on important discoveries emerging from the field of Epigenetics
Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current
Board Members:
David Mott